GLSHQGelesis HoldingsGLSHQ info
$0.00info0.00%24h
Global rank
Market cap$733.35
Change 7d0.00%
YTD Performance-99.50%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Business data

    Gelesis Holdings (GLSHQ) Stock Overview

    Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Further, it develops pre-clinical product GS300 for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Gelesis Holdings, Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts. On October 30, 2023, Gelesis Holdings, Inc., along its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

    GLSHQ Stock Information

    Symbol
    GLSHQ
    Address
    501 Boylston StreetBoston, MA 02116United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.gelesis.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    617 456 4718

    Gelesis Holdings (GLSHQ) Price Chart

    -
    Value:-

    Gelesis Holdings Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.00001
    N/A
    Market Cap
    $733.35
    N/A
    Shares Outstanding
    73.34M
    N/A
    Employees
    93.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org